IFNG and B-cell chronic lymphocytic leukemia: Furthermore, the mithralog did not alter the immune production of key antitumor effector molecules (IFN-γ and perforin), suggesting that EC-7072 does not exacerbate the immune dysregulation frequently observed in patients with CLL.